BioPharma

17 April, 2026 | Friday | News

DuPont Introduces Slurried AmberChrom XT Resins To Simplify Oligonucleotide And Peptide Purification

New slurried chromatography resins eliminate resin hydration step to help accelerate downstream purification of oligonucleotides and peptides DuPont announced the launch of DuPont™ AmberChrom™ XT20...

Lab

17 April, 2026 | Friday | News

Thermo Fisher Introduces PowerFlex Thermal Cycler To Simplify Complex PCR Workflows

A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible results Thermo Fisher Scientific Inc., the world leader i...

BioTech

17 April, 2026 | Friday | News

Hexagon AB To Acquire Waygate Technologies To Expand Non Destructive Testing Capabilities

Acquisition establishes Hexagon as a leading global provider of non-destructive testing (NDT) solutions, extending precision measurement from the surface to the inside of components and broadening Hexagon's f...

Contract Services

14 April, 2026 | Tuesday | News

Thermo Fisher Scientific Partners HealthVerity To Advance Data Driven Clinical Development

Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) marketplace, to enhance data-driven clinical developmen...

Consumer Health

31 March, 2026 | Tuesday | News

Aroa Biosurgery Reports Positive Primary Endpoint Achievement In Symphony RCT For Diabetic Foot Ulcers

Aroa Biosurgery Limited announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial achieved its primary endpoint. Symphony is AROA...

Medtech

17 April, 2026 | Friday | News

Waters Secures IVDR CE Mark For BD BACTEC FXI System Advancing Faster Bloodstream Infection Diagnostics

Achieves a ~3‑hour faster time to detection (~15% reduction) versus the prior generation system, per clinical study data,¹ enabling earlier targeted therapy. First‑of‑its‑kind blood volume measurement o...

Cell & Gene

15 April, 2026 | Wednesday | News

VectorBuilder Introduces MuteFree AAV To Address ITR Instability In Gene Therapy Development

VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, today announced MuteFree™ AAV, a high-stability AAV vector designed to address ITR instability, a common challenge in gene ...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close